Skip to content

DocGo DCGO Payments To Acquire Restricted Investments

Payments To Acquire Restricted Investments at other companies

Nutex Health Inc. logo
Nutex Health Inc.NUTX
$0-100%

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-69.6%
Enterprise value$32.67M-63.4%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireRestrictedInvestments.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's payments to acquire restricted investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's payments to acquire restricted investments?
DocGo (DCGO) reported payments to acquire restricted investments of $1.73M in Q1 2026.
What does payments to acquire restricted investments mean?
This represents cash outflows used to purchase investments that are subject to contractual or legal restrictions, such as collateral for insurance or debt obligations. These payments reduce immediate liquidity but are necessary to support operational requirements or credit facilities. Investors track this to understand how much cash is tied up in non-liquid, restricted assets.